Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos

[1]  T. Brüning,et al.  Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis , 2022, PloS one.

[2]  M. Metintaş,et al.  Serum Expression Levels of Certain miRNAs in Predicting Diagnosis, Prognosis, and Response to Chemotherapy in Malignant Pleural Mesothelioma , 2022, Balkan medical journal.

[3]  Yanlong Yang,et al.  Regulation of microRNA miR-197-3p/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by Circular RNA hsa_circ_0000285 promotes glioma progression , 2022, Bioengineered.

[4]  M. Bhasin,et al.  Survival Genie, a web platform for survival analysis across pediatric and adult cancers , 2021, Scientific Reports.

[5]  M. Bastami,et al.  Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer , 2022, Journal of oncology.

[6]  M. Fischler,et al.  A randomized trial to determine the minimum effective lidocaine volume for median nerve block using hydrodissection , 2022, Scientific reports.

[7]  P. Boschetto,et al.  Circulating microRNA-197-3p as a potential biomarker for asbestos exposure , 2021, Scientific Reports.

[8]  F. Di Virgilio,et al.  A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma , 2021, Frontiers in Oncology.

[9]  Liang Dong,et al.  Integrative Analysis Reveals a miRNA-mRNA Regulatory Network and Potential Causative Agents in the Asthmatic Airway Epithelium , 2021, Journal of asthma and allergy.

[10]  Yu Chen,et al.  MicroRNAs as Important Regulators Mediate the Multiple Differentiation of Mesenchymal Stromal Cells , 2021, Frontiers in Cell and Developmental Biology.

[11]  Zhi-De Hu,et al.  Diagnostic accuracy of circulating miR-126 for malignant pleural mesothelioma: a systematic review and meta-analysis , 2021, Translational cancer research.

[12]  Hayley E. Francies,et al.  Use of preclinical models for malignant pleural mesothelioma , 2021, Thorax.

[13]  Hongjuan Li,et al.  Hsa_circ_0025202 suppresses cell tumorigenesis and tamoxifen resistance via miR-197-3p/HIPK3 axis in breast cancer , 2021, World Journal of Surgical Oncology.

[14]  P. Pinton,et al.  Metformin Induces Apoptosis and Inhibits Notch1 in Malignant Pleural Mesothelioma Cells , 2021, Frontiers in Cell and Developmental Biology.

[15]  G. Zalcman,et al.  Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment , 2021, Therapeutic advances in medical oncology.

[16]  Huan Liu,et al.  Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression , 2021, Bioengineered.

[17]  Wenqi Zheng,et al.  Diagnostic value of microRNAs for malignant pleural mesothelioma: A mini‐review , 2020, Thoracic cancer.

[18]  H. Pass,et al.  Mesothelioma Biomarkers: Discovery in Search of Validation. , 2020, Thoracic surgery clinics.

[19]  Wenmin Zhang,et al.  Downregulation of circRNA_0000285 Suppresses Cervical Cancer Development by Regulating miR197-3p–ELK1 Axis , 2020, Cancer Management and Research.

[20]  Tong Liu,et al.  TUSC8 inhibits the development of osteosarcoma by sponging miR-197-3p and targeting EHD2 , 2020, International journal of molecular medicine.

[21]  H. Pass,et al.  Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[22]  Yunfeng Zhou,et al.  Exosomal miR‐1255b‐5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial‐to‐mesenchymal transition , 2020, Molecular oncology.

[23]  A. Pesatori,et al.  Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation , 2020, Frontiers in Oncology.

[24]  Qiang Huang,et al.  miR-197-3p Represses the Proliferation of Prostate Cancer by Regulating the VDAC1/AKT/β-catenin Signaling Axis , 2020, International journal of biological sciences.

[25]  N. Jain,et al.  Restoration of microRNA‐197 expression suppresses oncogenicity in fibrosarcoma through negative regulation of RAN , 2020, IUBMB life.

[26]  H. Olsson,et al.  The Menstrual Cycle and Risk of Breast Cancer: A Review , 2020, Frontiers in Oncology.

[27]  Emma M. Rath,et al.  The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer , 2020, Lung Cancer.

[28]  J. Rasko,et al.  The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy , 2019, Front. Oncol..

[29]  F. Galateau-Sallé,et al.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy , 2019, CA: a cancer journal for clinicians.

[30]  Guiyu Wang,et al.  Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer , 2019, Journal of Cancer.

[31]  M. Tognon,et al.  Association Between Simian Virus 40 and Human Tumors , 2019, Front. Oncol..

[32]  V. Villegas,et al.  Analyzing biological and molecular characteristics and genomic damage induced by exposure to asbestos , 2019, Cancer management and research.

[33]  M. Okada,et al.  Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma. , 2019, Oncology letters.

[34]  Hong Li,et al.  LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis , 2019, Molecules and cells.

[35]  E. Tirrò,et al.  Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 , 2019, Front. Oncol..

[36]  T. Brüning,et al.  Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case–control study , 2019, BMC Research Notes.

[37]  M. Tognon,et al.  Protocol for the long‐term culture of human primary keratinocytes from the normal colorectal mucosa , 2019, Journal of cellular physiology.

[38]  Yuan Yang,et al.  MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma , 2018, Oncology letters.

[39]  Zhiliang Gao,et al.  MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling , 2018, Cellular Physiology and Biochemistry.

[40]  N. Anber,et al.  Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa‐miR‐2053 and lncRNA‐RP1‐86D1.3 axis expression in malignant pleural mesothelioma , 2018, Journal of cellular biochemistry.

[41]  Zhi-Hu Liu,et al.  LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade. , 2018, Biochemical and biophysical research communications.

[42]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[43]  K. Oehl,et al.  Heterogeneity in Malignant Pleural Mesothelioma , 2018, International journal of molecular sciences.

[44]  G. Reid,et al.  Biomarkers in malignant pleural mesothelioma: current status and future directions. , 2018, Journal of thoracic disease.

[45]  R. Ferrari,et al.  New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma , 2018, Front. Oncol..

[46]  F. Galateau-Sallé,et al.  Malignant Mesothelioma and Its Non-Asbestos Causes. , 2018, Archives of pathology & laboratory medicine.

[47]  Zhiqiang Ma,et al.  Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome , 2018, Front. Endocrinol..

[48]  P. Laurent-Puig,et al.  Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective , 2018, Expert review of molecular diagnostics.

[49]  Chunlu Yang,et al.  miR-197-3p-induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines , 2017, Molecular medicine reports.

[50]  M. Tognon,et al.  Detection of Merkel Cell Polyomavirus DNA in Serum Samples of Healthy Blood Donors , 2017, Front. Oncol..

[51]  M. Tiseo,et al.  MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study , 2017, Disease markers.

[52]  J. V. van Meerbeeck,et al.  Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot? , 2017, Oncotarget.

[53]  D. Consonni,et al.  Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease , 2017, PloS one.

[54]  Su-jin Yang,et al.  miR-197: A novel biomarker for cancers. , 2016, Gene.

[55]  M. Ferracin,et al.  Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers , 2016, Oncotarget.

[56]  X. Niu,et al.  LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p , 2016, Tumor Biology.

[57]  D. Noonan,et al.  A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer , 2016, BMC Biotechnology.

[58]  A. Yoshimura,et al.  Clinical relevance of circulating cell-free microRNAs in ovarian cancer , 2016, Molecular Cancer.

[59]  N. Reguart,et al.  miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers , 2016, Clinical and Translational Oncology.

[60]  M. Fassan,et al.  Young investigator challenge: MicroRNA‐21/MicroRNA‐126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology , 2016, Cancer cytopathology.

[61]  X. Su,et al.  Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma , 2015, Oncoimmunology.

[62]  R. Hubbard,et al.  Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. , 2015, Lung cancer.

[63]  O. Shaker,et al.  Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. , 2015, Gene.

[64]  Qi Zhou,et al.  MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK , 2015, Tumor Biology.

[65]  M. Biffoni,et al.  Antitumor effect of miR-197 targeting in p53 wild-type lung cancer , 2014, Cell Death and Differentiation.

[66]  Subbaya Subramanian,et al.  Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation , 2014, Front. Genet..

[67]  Christopher M. Hindson,et al.  Absolute quantification by droplet digital PCR versus analog real-time PCR , 2013, Nature Methods.

[68]  Craig A. Poland,et al.  Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma , 2010, Particle and Fibre Toxicology.

[69]  John D. Minna,et al.  miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1 , 2009, Molecular Cancer Research.

[70]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[71]  C. Eng,et al.  A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[72]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[73]  K. Blyth,et al.  Progress and challenges in Mesothelioma: From bench to bedside. , 2018, Respiratory medicine.

[74]  P. Zucali.  Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma. , 2018, Journal of thoracic disease.

[75]  N. Maskell,et al.  Biomarkers in mesothelioma , 2018, Annals of clinical biochemistry.

[76]  M. Ferracin,et al.  Quantification of Circulating MicroRNAs by Droplet Digital PCR. , 2018, Methods in molecular biology.

[77]  Xinyang Lu,et al.  The Long Noncoding RNA HOTAIR Promotes Colorectal Cancer Progression by Sponging miR-197. , 2018, Oncology research.

[78]  Stuart Moss,et al.  Current Status and Future Directions , 2013 .

[79]  L. Trümper.  From bench to bedside , 2005, Medizinische Klinik.

[80]  C. Raggi,et al.  Mini review , 2004 .